Real-World Evidence & Data

Super intelligence tools and expert oversight for real-world evidence

Evidence Mastery combines the EvidenceAi™ Suite — super intelligence modules for every step of an RWE study — with expert scientific review, training and a complete education programme.

Products

Super intelligence modules from study concept to manuscript and dossier review.

Explore the Suite ↓

Services

Expert review, advisory, training and coaching.

See our services ↓

Academy

Books, courses, masterclass and publications.

Visit the Academy ↓
Products · EvidenceAi™ Suite

From study concept to manuscript: first drafts in minutes, not weeks1,2

Guideline-grounded super intelligence modules that take a study from idea to protocol, SAP, code, report and manuscript — each output feeding the next, with your expertise in the loop.

~99%calendar time saved per document (46.6 days on average)
~98%human effort saved per document (11.5 days on average)
7.85/10scientific quality (5.0 = equivalent to a human first draft)
9.2/10overall user satisfaction
To be presented at ISPOR Europe 2026 (Vienna, 8–11 November): 20 evaluations by 7 respondents from 7 organisations across 8 modules; mean scores on a 0–10 scale. Early-adopter sample; data collection ongoing. All outputs are first drafts for expert review.
  1. Toussi M, et al. A Generative AI Suite for Real-World Evidence Study Documentation: Multi-Module Validation Across Pharmacoepidemiological Deliverables. ISPOR Europe 2026, Vienna, poster RWD21. Value Health. 2026;29(12S). Download poster (PDF)
  2. Toussi M, et al. AI-Assisted RWE Study Design and Reporting: Quantifying Time Savings and Scientific Equivalence. ISPOR Europe 2026, Vienna, poster MSR114. Download poster (PDF)
The RWE study pipeline
HARPER · GVP VIII · ICH E9(R1)
Development
ProtocolAi™ SAPAi™ CodeAi™ DataAi™ · soon AnalyzeAi™ · soon
11 live modules · 2 coming soon. Details, sample outputs and credit costs on the Products page →
Evidence & validation

Evaluated in a multi-organisation pilot

Two research abstracts on the EvidenceAi™ Suite are accepted for ISPOR Europe 2026 (Vienna, 8–11 November). Every output remains a draft for expert review — the human-in-the-loop principle is built into the platform.

Publications & evidence →
402study documents generated in the pilot
39pilot users
20structured evaluations from 7 organisations
How it works

From first draft to expert-reviewed deliverable

One workflow, two kinds of strength: the speed of super intelligence and the judgement of experienced scientists.

1
GenerateUse the EvidenceAi™ Suite to draft protocols, analysis plans, code, reports and manuscripts, step by step, in minutes rather than weeks.
2
ReviewYour team reviews the output, or ours does: our scientists check, correct and strengthen every deliverable against the relevant guidelines.
3
DeliverReceive documents that are expert-approved and ready for your quality system, regulators or journals.
Securely built platform Your documents are not retained Use the AI your organisation trusts How we protect your data →
Services

Expert services alongside the platform

Generate with the Suite, then have our scientists review, validate and finalise. One turnkey service from first draft to expert-reviewed deliverable — plus advisory, training and coaching for your team.

Scientific oversight & reviewA turnkey service: protocols, SAPs, code, reports and manuscripts generated with the Suite, then reviewed, validated and finalised by our scientists.
Scientific advisorySABs, DMCs, protocol review and methodological oversight.
Corporate trainingBespoke programmes for pharma, CRO, regulatory and HTA teams — EN/FR.
Keynote speakingConferences, symposia and corporate events on RWE science and strategy.
Board & governanceNon-executive and governance roles in health data and digital health.
Career coachingAdvice and coaching for RWE and pharmacoepidemiology professionals.
Academy

A complete curriculum for real-world evidence

From foundational principles to advanced causal methods — in print, in audio, on video and in person.

Explore the Academy →
Insights

Highlights from the Evidence Mastery Newsletter

Read and subscribe on LinkedIn →

Founded by Dr Massoud Toussi, MD, PhD, MBA — a physician and pharmacoepidemiologist with twenty years of real-world evidence leadership.

About Evidence Mastery →

One account. Tools, courses and resources.

Create your free account to start with the EvidenceAi™ Suite and access your courses in one place.